Autologous stem cell transplantation in multiple myeloma: a single center experience.
This study shows the feasibility and safety of autologous stem cell transplantation in 32 of 98 multiple myeloma patients referred to our institution over a 3-year period. Complete response rate was 19% and partial response rate 58%. A significantly better outcome was shown among newly diagnosed patients in comparison with pretreated patients.
Patriarca
F
F
Fanin
R
R
Silvestri
F
F
Damiani
D
D
Baccarani
M
M
D000328:Adult; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D014182:Transplantation, Autologous